NeuroOne Medical Technologies Corporation (NMTC)

NASDAQ: NMTC · Real-Time Price · USD

2.030

-0.120 (-5.58%)

At close: Aug 21, 2026, 4:00 PM EDT

2.310

+0.280 (13.79%)

After-hours: Aug 21, 2026, 7:39 PM EDT

NMTC Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	12.47	12.1	3.45	3.41	2.12	0.24
Revenue Growth	88.09%	250.35%	1.33%	60.73%	772.60%	-87.39%
Cost of Revenue	9.6	8.94	7.44	8.44	5.17	4.2
Gross Profit	2.87	3.16	-3.99	-5.03	-3.05	-3.96
Selling, General & Admin	7.77	7.38	7.9	6.93	6.98	6.26
Operating Expenses	10.77	7.38	7.9	6.93	6.98	6.26
Operating Income	-7.9	-4.23	-11.89	-11.96	-10.03	-10.22
Interest Expense	-	-0.2	-0.1	-	-	-0
Interest & Investment Income	-	-	-	0.2	-	-
Other Non Operating Income (Expenses)	0.93	0.82	-0.33	-0.07	0.03	-0.01
EBT Excluding Unusual Items	-6.97	-3.61	-12.32	-11.83	-10	-10.23
Gain (Loss) on Sale of Assets	-	-	-	-0.03	-	-
Legal Settlements	-	-	-	-	-	0.2
Other Unusual Items	-0.48	-	-	-	-	0.08
Pretax Income	-7.45	-3.61	-12.32	-11.86	-10	-9.95
Net Income	-7.45	-3.61	-12.32	-11.86	-10	-9.95
Net Income to Common	-7.45	-3.61	-12.32	-11.86	-10	-9.95
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	8	7	4	3	3	2
Shares Outstanding (Diluted)	8	7	4	3	3	2
Shares Change	44.82%	50.03%	47.69%	13.27%	49.56%	97.52%
EPS (Basic)	-0.88	-0.54	-2.76	-3.93	-3.75	-5.58
EPS (Diluted)	-0.95	-0.54	-2.76	-3.93	-3.75	-5.58
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Free Cash Flow	-7.16	-2.92	-11.13	-13.27	-7.79	-8.67
Free Cash Flow Per Share	-0.85	-0.44	-2.50	-4.39	-2.92	-4.86
Gross Margin	23.00%	26.11%	-115.42%	-147.58%	-143.93%	-
Operating Margin	-63.36%	-34.94%	-344.26%	-350.84%	-473.14%	-4205.75%
Profit Margin	-59.71%	-29.80%	-356.74%	-348.03%	-471.67%	-4094.60%
Free Cash Flow Margin	-57.44%	-24.13%	-322.39%	-389.45%	-367.67%	-3568.48%
EBITDA	-7.66	-3.96	-11.64	-11.76	-9.91	-10.14
EBITDA Margin	-61.46%	-32.77%	-	-	-	-
D&A For EBITDA	0.24	0.26	0.25	0.2	0.12	0.08
EBIT	-7.9	-4.23	-11.89	-11.96	-10.03	-10.22
EBIT Margin	-63.36%	-34.94%	-	-	-	-
Advertising Expenses	-	0.17	0.11	0.17	0.27	0.34

SEC Filings: 10-K · 10-Q